Dofetilide: a new class III antiarrhythmic agent
@article{Roukoz2007DofetilideAN, title={Dofetilide: a new class III antiarrhythmic agent}, author={H. Roukoz and W. Saliba}, journal={Expert Review of Cardiovascular Therapy}, year={2007}, volume={5}, pages={19 - 9} }
Dofetilide is a relatively new class III antiarrhythmic agent that selectively blocks the rapid component of the cardiac ion channel delayed rectifier current. This results in an increase in the action potential duration and effective refractory period of the myocyte, thereby terminating reentrant tachyarrhythmias and preventing their re-induction. Oral dofetilide is effective in the conversion of atrial fibrillation and flutter to sinus rhythm and in the maintenance of sinus rhythm after… CONTINUE READING
Topics from this paper
56 Citations
Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
- Medicine
- Cardiology journal
- 2008
- 35
Newer Antiarrhythmic Agents for Atrial Fibrillation: Shall we Eventually do away with Proarrhythmia?
- Medicine
- 2008
Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.
- Medicine
- Indian heart journal
- 2014
- 21
Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses
- Medicine
- Journal of cardiovascular pharmacology
- 2018
- 10
Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
- Medicine
- Congenital heart disease
- 2014
- 15
Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting.
- Medicine
- The American journal of cardiology
- 2008
- 16
Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter
- Medicine
- Journal of Interventional Cardiac Electrophysiology
- 2008
- 24
Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin
- Chemistry, Medicine
- Front. Physiol.
- 2017
- 20
- PDF
Dofetilide-Induced Microvolt T-Wave Alternans
- Medicine, Computer Science
- 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
- 2019
References
SHOWING 1-10 OF 72 REFERENCES
Azimilide dihydrochloride, a novel antiarrhythmic agent.
- Medicine
- The American journal of cardiology
- 1998
- 64
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.
- Medicine
- Journal of the American College of Cardiology
- 1997
- 188
Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group.
- Medicine
- The American journal of cardiology
- 1995
- 55
Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris.
- Medicine
- The American journal of cardiology
- 1992
- 55
Clinical and electrophysiologic effects of dofetilide in patients with supraventricular tachyarrhythmias.
- Medicine
- Journal of cardiovascular pharmacology
- 1997
- 8
Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
- Medicine
- American heart journal
- 1999
- 32
Cardiac and hemodynamic effects of intravenous dofetilide in patients with heart failure.
- Medicine
- The American journal of cardiology
- 2001
- 10
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
- Medicine
- The New England journal of medicine
- 1999
- 889